Zydus Lifesciences Ltd (ZYDUSLIFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 290229,
    "name": "Zydus Lifesci.",
    "stock_name": "Zydus Lifesci.",
    "full_name": "Zydus Lifesciences Ltd",
    "name_url": "stocks-analysis/zydus-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,078.50",
    "chg": 59.55,
    "chgp": "5.84%",
    "dir": 1,
    "prev_price": "1,018.95",
    "mcapval": "108,522.34 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532321,
    "symbol": "ZYDUSLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE010B01027",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "62.94 lacs",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zydus-lifesci-290229-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Zydus Lifesciences Ltd to 52-Week High of Rs 1083",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-hits-new-52-week-high-of-rs1083-on-20-may-2026-4000504",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_priceRelatedfactors_4000504.png",
        "date": "2026-05-20 09:37:54",
        "description": "With a decisive surge to Rs 1083 on 20 May 2026, Zydus Lifesciences Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This rally has been underpinned by a confluence of bullish technical indicators and sustained upward price action, even as the broader market trades under pressure."
      },
      {
        "title": "Zydus Lifesciences Ltd Surges 5.31% to Day's High of Rs 1079.2 — Outperforms Sector by 5.76 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-hits-intraday-high-with-531-surge-on-20-may-2026-4000483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_priceRelatedfactors_4000483.png",
        "date": "2026-05-20 09:31:09",
        "description": "While the Sensex declined 0.64% on 20 May 2026, Zydus Lifesciences Ltd surged 5.31%, reaching a new 52-week high of Rs 1079.2. This 5.76-percentage-point outperformance over its Pharmaceuticals &amp; Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide uplift."
      },
      {
        "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4000049",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_technicaldot_4000049.png",
        "date": "2026-05-20 08:01:01",
        "description": "Zydus Lifesciences Ltd has demonstrated a notable shift in price momentum, supported by a series of technical indicator upgrades that suggest a cautiously optimistic outlook for this mid-cap pharmaceutical player. The stock’s recent 2.8% day gain and a fresh upgrade from Hold to Buy by MarketsMOJO underscore growing investor confidence amid mixed but improving technical signals."
      },
      {
        "title": "Zydus Lifesciences Ltd Reports Flat Quarterly Performance Amid Margin Expansion",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-reports-flat-quarterly-performance-amid-margin-expansion-3999955",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_fintrenddot_3999955.png",
        "date": "2026-05-20 08:00:07",
        "description": "Zydus Lifesciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended March 2026, prompting an upgrade in its Mojo Grade from Hold to Buy. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics, signalling a stabilisation in its growth trajectory after a period of negative trends."
      },
      {
        "title": "Zydus Lifesciences Q4 FY25: Strong Finish with 8.7% Profit Growth Amid Margin Volatility",
        "link": "https://www.marketsmojo.com/news/result-analysis/zydus-lifesciences-q4-fy25-strong-finish-with-87-profit-growth-amid-margin-volatility-3999884",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_quaterlyResult_3999884.png",
        "date": "2026-05-19 22:15:52",
        "description": "Zydus Lifesciences Ltd., one of India's leading innovation-driven pharmaceutical companies, reported consolidated net profit of ₹1,272.50 crores for Q4 FY25 (quarter ended March 2026), marking an 8.68% year-on-year increase from ₹1,170.90 crores in Q4 FY24. The quarter-on-quarter performance showed stronger momentum, with profits surging 22.11% from ₹1,042.10 crores in Q3 FY25. With a market capitalisation of ₹1,01,459 crores and trading at ₹1,018.95 on May 19, 2026, the stock has responded positively to these results, gaining 2.8% in the latest trading session."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Renewed Market Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-signalling-renewed-market-interest-3999213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_3999213.png",
        "date": "2026-05-19 15:00:08",
        "description": "Zydus Lifesciences Ltd has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical mid-cap stock outperformed its sector peers and is trading near its 52-week high, reflecting growing bullish sentiment among traders and investors alike."
      },
      {
        "title": "Zydus Lifesciences Ltd Surges 5.33% to Day's High of Rs 1048.45 — Outperforms Sector by 4.77 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-hits-intraday-high-with-533-surge-on-19-may-2026-3999201",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_priceRelatedfactors_3999201.png",
        "date": "2026-05-19 14:46:04",
        "description": "The Sensex edged just 0.01% higher while Zydus Lifesciences Ltd surged 5.33% on 19 Jun 2026, hitting an intraday high of Rs 1048.45. That 4.77-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a broad market lift."
      },
      {
        "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-amid-mixed-indicators-3997789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_technicaldot_3997789.png",
        "date": "2026-05-19 08:01:30",
        "description": "Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of indicator signals. Despite a recent downgrade in daily moving averages and a slight dip in price, the stock continues to show resilience in weekly and monthly technicals, suggesting a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Zydus Lifesciences Ltd Valuation Shifts: From Attractive to Fair Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-valuation-shifts-from-attractive-to-fair-amid-sector-dynamics-3995871",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_valuationdot_3995871.png",
        "date": "2026-05-18 08:00:40",
        "description": "Zydus Lifesciences Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating as of mid-May 2026. This change reflects evolving market perceptions amid a competitive pharmaceutical sector landscape, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios adjusting closer to peer averages. Investors are now reassessing the stock’s price attractiveness in light of these developments and its recent performance relative to benchmarks."
      }
    ],
    "total": 666,
    "sid": "290229",
    "stock_news_url": "https://www.marketsmojo.com/news/zydus-lifesciences-290229"
  },
  "announcements": [
    {
      "caption": "Update on board meeting",
      "datetime": "13-May-2026",
      "details": "Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve Update on board meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "13-May-2026",
      "details": "Acquisition of shares of Assertio Holdings Inc.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "13-May-2026",
      "details": "Q4 FY26 post results earning call details",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has declared <strong>1100%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:5</strong> stock split, ex-date: 06 Oct 15",
          "dt": "2015-10-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 05 Apr 10",
          "dt": "2010-04-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Zydus Lifesciences Ltd to 52-Week High of Rs 1083

2026-05-20 09:37:54

With a decisive surge to Rs 1083 on 20 May 2026, Zydus Lifesciences Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This rally has been underpinned by a confluence of bullish technical indicators and sustained upward price action, even as the broader market trades under pressure.

Read full news article

Zydus Lifesciences Ltd Surges 5.31% to Day's High of Rs 1079.2 — Outperforms Sector by 5.76 Percentage Points

2026-05-20 09:31:09

While the Sensex declined 0.64% on 20 May 2026, Zydus Lifesciences Ltd surged 5.31%, reaching a new 52-week high of Rs 1079.2. This 5.76-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide uplift.

Read full news article

Zydus Lifesciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-20 08:01:01

Zydus Lifesciences Ltd has demonstrated a notable shift in price momentum, supported by a series of technical indicator upgrades that suggest a cautiously optimistic outlook for this mid-cap pharmaceutical player. The stock’s recent 2.8% day gain and a fresh upgrade from Hold to Buy by MarketsMOJO underscore growing investor confidence amid mixed but improving technical signals.

Read full news article

Zydus Lifesciences Ltd Reports Flat Quarterly Performance Amid Margin Expansion

2026-05-20 08:00:07

Zydus Lifesciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended March 2026, prompting an upgrade in its Mojo Grade from Hold to Buy. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics, signalling a stabilisation in its growth trajectory after a period of negative trends.

Read full news article

Zydus Lifesciences Q4 FY25: Strong Finish with 8.7% Profit Growth Amid Margin Volatility

2026-05-19 22:15:52

Zydus Lifesciences Ltd., one of India's leading innovation-driven pharmaceutical companies, reported consolidated net profit of ₹1,272.50 crores for Q4 FY25 (quarter ended March 2026), marking an 8.68% year-on-year increase from ₹1,170.90 crores in Q4 FY24. The quarter-on-quarter performance showed stronger momentum, with profits surging 22.11% from ₹1,042.10 crores in Q3 FY25. With a market capitalisation of ₹1,01,459 crores and trading at ₹1,018.95 on May 19, 2026, the stock has responded positively to these results, gaining 2.8% in the latest trading session.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Renewed Market Interest

2026-05-19 15:00:08

Zydus Lifesciences Ltd has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical mid-cap stock outperformed its sector peers and is trading near its 52-week high, reflecting growing bullish sentiment among traders and investors alike.

Read full news article

Zydus Lifesciences Ltd Surges 5.33% to Day's High of Rs 1048.45 — Outperforms Sector by 4.77 Percentage Points

2026-05-19 14:46:04

The Sensex edged just 0.01% higher while Zydus Lifesciences Ltd surged 5.33% on 19 Jun 2026, hitting an intraday high of Rs 1048.45. That 4.77-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a broad market lift.

Read full news article

Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-05-19 08:01:30

Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of indicator signals. Despite a recent downgrade in daily moving averages and a slight dip in price, the stock continues to show resilience in weekly and monthly technicals, suggesting a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Zydus Lifesciences Ltd Valuation Shifts: From Attractive to Fair Amid Sector Dynamics

2026-05-18 08:00:40

Zydus Lifesciences Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating as of mid-May 2026. This change reflects evolving market perceptions amid a competitive pharmaceutical sector landscape, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios adjusting closer to peer averages. Investors are now reassessing the stock’s price attractiveness in light of these developments and its recent performance relative to benchmarks.

Read full news article

View All News